{"id":"https://openalex.org/W4283372970","doi":"https://doi.org/10.1093/jacamr/dlac053.011","title":"P11 Evaluation of in vitro activity of double \u03b2-lactam therapy and relationship with PBP activity in Escherichia coli isolates","display_name":"P11 Evaluation of in vitro activity of double \u03b2-lactam therapy and relationship with PBP activity in Escherichia coli isolates","publication_year":2022,"publication_date":"2022-05-31","ids":{"openalex":"https://openalex.org/W4283372970","doi":"https://doi.org/10.1093/jacamr/dlac053.011","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9156032"},"language":"en","primary_location":{"id":"doi:10.1093/jacamr/dlac053.011","doi":"https://doi.org/10.1093/jacamr/dlac053.011","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jacamr/dlac053.011","pdf_url":null,"source":{"id":"https://openalex.org/S4210190703","display_name":"JAC-Antimicrobial Resistance","issn_l":"2632-1823","issn":["2632-1823"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAC-Antimicrobial Resistance","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/jacamr/dlac053.011","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058151068","display_name":"Joseph Suich","orcid":"https://orcid.org/0000-0001-5543-6555","observed_orcids":["https://orcid.org/0000-0001-5543-6555"]},"institutions":[{"id":"https://openalex.org/I191240316","display_name":"University of Hull","ror":"https://ror.org/04nkhwh30","country_code":"GB","type":"education","lineage":["https://openalex.org/I191240316"]},{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J Suich","raw_affiliation_strings":["Hull University Teaching Hospitals NHS Trust , Hull, UK","University of York , York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull University Teaching Hospitals NHS Trust , Hull, UK","institution_ids":["https://openalex.org/I191240316"]},{"raw_affiliation_string":"University of York , York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088148254","display_name":"Marjan W. van der Woude","orcid":"https://orcid.org/0000-0002-0446-8829","observed_orcids":["https://orcid.org/0000-0002-0446-8829"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M Van der Woude","raw_affiliation_strings":["University of York , York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of York , York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109984973","display_name":"D Wearmouth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191240316","display_name":"University of Hull","ror":"https://ror.org/04nkhwh30","country_code":"GB","type":"education","lineage":["https://openalex.org/I191240316"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D Wearmouth","raw_affiliation_strings":["Hull University Teaching Hospitals NHS Trust , Hull, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull University Teaching Hospitals NHS Trust , Hull, UK","institution_ids":["https://openalex.org/I191240316"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P Burns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191240316","display_name":"University of Hull","ror":"https://ror.org/04nkhwh30","country_code":"GB","type":"education","lineage":["https://openalex.org/I191240316"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P Burns","raw_affiliation_strings":["Hull University Teaching Hospitals NHS Trust , Hull, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull University Teaching Hospitals NHS Trust , Hull, UK","institution_ids":["https://openalex.org/I191240316"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087716379","display_name":"Gavin D Barlow","orcid":"https://orcid.org/0000-0002-4018-6685","observed_orcids":["https://orcid.org/0000-0002-4018-6685"]},"institutions":[{"id":"https://openalex.org/I191240316","display_name":"University of Hull","ror":"https://ror.org/04nkhwh30","country_code":"GB","type":"education","lineage":["https://openalex.org/I191240316"]},{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G Barlow","raw_affiliation_strings":["Hull University Teaching Hospitals NHS Trust , Hull, UK","University of York , York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull University Teaching Hospitals NHS Trust , Hull, UK","institution_ids":["https://openalex.org/I191240316"]},{"raw_affiliation_string":"University of York , York, UK","institution_ids":["https://openalex.org/I52099693"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1794,"currency":"GBP","value_usd":2219},"apc_paid":{"value":1794,"currency":"GBP","value_usd":2219},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"Supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.023600000888109207,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/penicillin-binding-proteins","display_name":"penicillin-binding proteins","score":0.7670000195503235},{"id":"https://openalex.org/keywords/penicillin-binding-protein-2","display_name":"penicillin-binding protein 2","score":0.7649999856948853},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.7760000228881836},{"id":"https://openalex.org/keywords/antibiotic-synergy","display_name":"antibiotic synergy","score":0.625},{"id":"https://openalex.org/keywords/ceftazidime-avibactam","display_name":"ceftazidime-avibactam","score":0.8619999885559082},{"id":"https://openalex.org/keywords/beta-lactamase-inhibitors","display_name":"beta-lactamase inhibitors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/extended-spectrum-beta-lactamase","display_name":"extended-spectrum beta-lactamase","score":0.8610000014305115},{"id":"https://openalex.org/keywords/carbapenemase","display_name":"carbapenemase","score":0.9010000228881836},{"id":"https://openalex.org/keywords/in-vitro-antimicrobial-activity","display_name":"in vitro antimicrobial activity","score":0.5519999861717224},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4959999918937683},{"id":"https://openalex.org/keywords/peptidoglycan-synthesis","display_name":"peptidoglycan biosynthesis","score":0.6800000071525574},{"id":"https://openalex.org/keywords/amoxicillin-clavulanic-acid","display_name":"amoxicillin-clavulanic acid","score":0.5920000076293945}],"concepts":[{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.8637735843658447},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.7414499521255493},{"id":"https://openalex.org/C547475151","wikidata":"https://www.wikidata.org/wiki/Q25419","display_name":"Escherichia coli","level":3,"score":0.7379198670387268},{"id":"https://openalex.org/C2777406300","wikidata":"https://www.wikidata.org/wiki/Q15410251","display_name":"Avibactam","level":5,"score":0.7286302447319031},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6702824831008911},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6004116535186768},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.5327240228652954},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.531356155872345},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48492151498794556},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.46558821201324463},{"id":"https://openalex.org/C2778910516","wikidata":"https://www.wikidata.org/wiki/Q380136","display_name":"Enterobacteriaceae","level":4,"score":0.4560905992984772},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.3200668394565582},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.11686074733734131},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09624195098876953},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.053228795528411865},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/jacamr/dlac053.011","doi":"https://doi.org/10.1093/jacamr/dlac053.011","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jacamr/dlac053.011","pdf_url":null,"source":{"id":"https://openalex.org/S4210190703","display_name":"JAC-Antimicrobial Resistance","issn_l":"2632-1823","issn":["2632-1823"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAC-Antimicrobial Resistance","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9156032","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9156032/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAC Antimicrob Resist","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/jacamr/dlac053.011","doi":"https://doi.org/10.1093/jacamr/dlac053.011","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jacamr/dlac053.011","pdf_url":null,"source":{"id":"https://openalex.org/S4210190703","display_name":"JAC-Antimicrobial Resistance","issn_l":"2632-1823","issn":["2632-1823"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAC-Antimicrobial Resistance","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4390521418","https://openalex.org/W4380686000","https://openalex.org/W7016374712","https://openalex.org/W2372651457","https://openalex.org/W2420696814","https://openalex.org/W2989326983","https://openalex.org/W2128851761","https://openalex.org/W4408573173","https://openalex.org/W4292059632","https://openalex.org/W7217400392"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"PBPs":[2],"are":[3],"involved":[4],"in":[5,46,68,98,125,150,217,228,246,256,261,332],"the":[6,12,20,31,76,110,143,157,185,275,305,335],"construction":[7],"of":[8,15,22,122,140,168,199,207,222,232,240,304,337,358],"peptidoglycan,":[9],"which":[10],"is":[11,26,353],"major":[13],"constituent":[14],"bacterial":[16,37],"cell":[17],"walls":[18],"and":[19,40,83,97,134,148,174,204,224,234,350],"target":[21],"\u03b2-lactam":[23,80,114,312],"antibiotics.":[24],"There":[25],"little":[27],"published":[28],"research":[29],"analysing":[30],"relationship":[32,77,111],"between":[33,78,112],"\u03b2-lactams":[34],"with":[35,48,152,253,269,290,299],"differing":[36],"PBP":[38,60],"targets":[39],"how":[41],"they":[42],"can":[43],"be":[44,343],"manipulated":[45],"combinations":[47,116,170,181,188,202,209,249,276,292,301,308],"respect":[49],"to":[50,66,286],"clinical":[51],"or":[52,279],"microbiological":[53],"(e.g.":[54],"resistance)":[55],"outcomes":[56],"(i.e.":[57],"does":[58],"expanded":[59],"activity":[61,100],"via":[62],"a":[63,90,311,315,324,338],"combination":[64,151],"lead":[65],"better":[67],"vitro/in":[69],"vivo":[70],"outcomes).":[71],"Objectives":[72],"To":[73],"systematically":[74,108],"explore":[75],"double":[79,113],"therapy":[81,115],"(with":[82],"without":[84],"at":[85],"least":[86],"one":[87],"partner":[88,316],"being":[89],"\u03b2-lactamase":[91,339],"inhibitor":[92,313,340],"antibiotic":[93,271],"such":[94,359],"as":[95,314],"co-amoxiclav)":[96],"vitro":[99],"against":[101,117],"susceptible":[102,130,236,263],"Escherichia":[103],"coli":[104,120],"strains.":[105],"Methods":[106],"We":[107],"explored":[109],"seven":[118],"E.":[119],"strains":[121],"variable":[123],"resistance":[124],"vitro.":[126],"This":[127,321],"included":[128,194],"fully":[129,235,262],"isolates,":[131],"ESBL":[132,218],"producers":[133,136,219],"carbapenemase":[135],"(CPEs).":[137],"For":[138],"each":[139],"10":[141],"antibiotics,":[142,155],"MIC":[144],"was":[145,213,267],"determined":[146],"individually,":[147],"subsequently":[149],"9":[153],"further":[154],"using":[156,346],"MTS\u2122":[158],"\u2018cross\u2019":[159],"synergy":[160,173,278],"method":[161,349],"(Liofilchem,":[162],"2012).":[163],"Results":[164],"Overall,":[165],"86/630":[166],"(13.6%)":[167],"all":[169,200],"tested":[171],"showed":[172,182,190],"408/630":[175],"(64.8%)":[176],"were":[177,244,282],"additive;":[178],"136/630":[179],"(21.6%)":[180],"indifference.":[183],"Of":[184],"86":[186],"\u2018bug\u2013drug\u2019":[187],"that":[189],"synergy,":[191,333],"42/86":[192],"(49%)":[193],"ceftazidime/avibactam,":[195],"representing":[196],"42/126":[197],"(33%)":[198],"ceftazidime/avibactam-based":[201],"tested,":[203,277],"56/86":[205],"(65%)":[206],"synergistic":[208,306],"covered":[210],"PBP2.":[211],"Synergy":[212],"most":[214],"commonly":[215],"detected":[216],"(58/86;":[220],"67%":[221],"combinations)":[223,233],"less":[225],"frequently":[226],"seen":[227,245],"CPEs":[229],"(2/86;":[230],"2%":[231],"isolates":[237],"(8/86;":[238],"9%":[239],"combinations).":[241],"Additive":[242],"effects":[243,281,360],"92/180":[247],"(51%)":[248],"versus":[250,258],"ESBLs,":[251],"compared":[252],"18/90":[254],"(20%)":[255],"CPEs,":[257],"154/180":[259],"(86%)":[260],"isolates.":[264],"No":[265],"antagonism":[266],"identified":[268,309],"any":[270],"combination.":[272],"Conclusions":[273],"In":[274],"additive":[280],"common":[283],"(78%);":[284],"similar":[285],"our":[287],"previous":[288],"work":[289],"fosfomycin/\u03b2-lactam":[291],"(89%),":[293],"but":[294],"higher":[295],"than":[296],"we":[297],"found":[298],"fosfomycin/non-\u03b2-lactam":[300],"(28%).":[302],"Many":[303],"bug\u2013drug":[307],"contained":[310],"and/or":[317],"provided":[318],"PBP2":[319,327],"activity.":[320],"provisionally":[322],"suggests":[323],"role":[325],"for":[326],"(also":[328],"targeted":[329],"by":[330],"avibactam)":[331],"although":[334],"presence":[336],"may":[341],"also":[342],"important.":[344],"Confirmation":[345],"an":[347],"alternative":[348],"mechanistic":[351],"elucidation":[352],"required.":[354],"The":[355],"clinical/microbiological":[356],"importance":[357],"remains":[361],"unclear.":[362]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2022-06-25T00:00:00"}